Screening for clinically significant non-deletional alpha thalassaemia mutations by pyrosequencing.
Non-deletional α(+)-thalassaemia is associated with a higher degree of morbidity and mortality than deletional forms of α(+)-thalassaemia. Screening for the common deletional forms of α-thalassaemia by Gap-PCR is widely practiced; however, the detection of non-deletional α-thalassaemia mutations is...
主要な著者: | Haywood, A, Dreau, H, Timbs, A, Schuh, A, Old, J, Henderson, S |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2010
|
類似資料
-
Multiplex ligation-dependent probe amplification identification of 17 different beta-globin gene deletions (including four novel mutations) in the UK population.
著者:: Gallienne, A, 等
出版事項: (2009) -
Non-deletional alpha thalassaemia: a review
著者:: Ibrahim Kalle Kwaifa, 等
出版事項: (2020-06-01) -
Non-deletional alpha thalassaemia: a review of emerging therapy
著者:: Khairil Wahidin, Nurfhaezah, 等
出版事項: (2021) -
Screening of concurrent alpha-Thalassaemia 1 in beta-Thalassaemia carriers
著者:: Chong, Y.M., 等
出版事項: (2006) -
Screening of Alpha-Thalassaemia 1 in Beta-Thalassaemia Carriers
著者:: Chong, Yi Min
出版事項: (2005)